Menu
GeneBe

5-160427815-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004219.4(PTTG1):c.471G>T(p.Lys157Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 152,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)

Consequence

PTTG1
NM_004219.4 missense

Scores

4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.838
Variant links:
Genes affected
PTTG1 (HGNC:9690): (PTTG1 regulator of sister chromatid separation, securin) The encoded protein is a homolog of yeast securin proteins, which prevent separins from promoting sister chromatid separation. It is an anaphase-promoting complex (APC) substrate that associates with a separin until activation of the APC. The gene product has transforming activity in vitro and tumorigenic activity in vivo, and the gene is highly expressed in various tumors. The gene product contains 2 PXXP motifs, which are required for its transforming and tumorigenic activities, as well as for its stimulation of basic fibroblast growth factor expression. It also contains a destruction box (D box) that is required for its degradation by the APC. The acidic C-terminal region of the encoded protein can act as a transactivation domain. The gene product is mainly a cytosolic protein, although it partially localizes in the nucleus. Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19820955).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTTG1NM_004219.4 linkuse as main transcriptc.471G>T p.Lys157Asn missense_variant 5/6 ENST00000352433.10
PTTG1NM_001282382.1 linkuse as main transcriptc.471G>T p.Lys157Asn missense_variant 4/5
PTTG1NM_001282383.1 linkuse as main transcriptc.471G>T p.Lys157Asn missense_variant 5/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTTG1ENST00000352433.10 linkuse as main transcriptc.471G>T p.Lys157Asn missense_variant 5/61 NM_004219.4 P1
PTTG1ENST00000393964.1 linkuse as main transcriptc.471G>T p.Lys157Asn missense_variant 4/51 P1
PTTG1ENST00000520452.5 linkuse as main transcriptc.471G>T p.Lys157Asn missense_variant 5/63 P1
PTTG1ENST00000519287.1 linkuse as main transcriptn.474G>T non_coding_transcript_exon_variant 5/65

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Cov.:
30
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152168
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000529

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 11, 2023The c.471G>T (p.K157N) alteration is located in exon 5 (coding exon 4) of the PTTG1 gene. This alteration results from a G to T substitution at nucleotide position 471, causing the lysine (K) at amino acid position 157 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.63
Cadd
Benign
23
Dann
Uncertain
1.0
DEOGEN2
Benign
0.12
T;T;T
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.81
D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.20
T;T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.8
L;L;L
MutationTaster
Benign
0.91
D;D;D
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Benign
0.096
Sift
Benign
0.13
T;T;T
Sift4G
Benign
0.19
T;T;T
Polyphen
0.95
P;P;P
Vest4
0.17
MutPred
0.45
Loss of ubiquitination at K157 (P = 0.0034);Loss of ubiquitination at K157 (P = 0.0034);Loss of ubiquitination at K157 (P = 0.0034);
MVP
0.62
MPC
0.36
ClinPred
0.68
D
GERP RS
4.8
Varity_R
0.074
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs896135688; hg19: chr5-159854822; API